Welcome to LookChem.com Sign In|Join Free
  • or
2-Fluoro-6-nitroanisole is a chemical compound that is a derivative of 2-Fluoro-6-nitrophenol (F594845). It is characterized by the presence of a fluorine atom at the 2nd position and a nitro group at the 6th position on the anisole molecule.

484-94-6

Post Buying Request

484-94-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

484-94-6 Usage

Uses

Used in Agriculture:
2-Fluoro-6-nitroanisole is used as a plant growth regulator for promoting growth and development in various types of plants. It helps in enhancing the overall productivity and quality of crops by regulating the growth processes at the cellular level.

Check Digit Verification of cas no

The CAS Registry Mumber 484-94-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,8 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 484-94:
(5*4)+(4*8)+(3*4)+(2*9)+(1*4)=86
86 % 10 = 6
So 484-94-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H6FNO3/c1-12-7-5(8)3-2-4-6(7)9(10)11/h2-4H,1H3

484-94-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-fluoro-2-methoxy-3-nitrobenzene

1.2 Other means of identification

Product number -
Other names BENZENE,1-FLUORO-2-METHOXY-3-NITRO

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:484-94-6 SDS

484-94-6Synthetic route

1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

3-fluoro-2-methoxyaniline
437-83-2

3-fluoro-2-methoxyaniline

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethyl acetate for 24h;94%
With platinum Hydrogenation;
With hydrogen; palladium on activated charcoal In methanol at 20℃; for 27h;
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

2-(Diethylamino)ethanol
100-37-8

2-(Diethylamino)ethanol

N,N-diethyl-2-(2-methoxy-3-nitrophenoxy)ethanamine

N,N-diethyl-2-(2-methoxy-3-nitrophenoxy)ethanamine

Conditions
ConditionsYield
Stage #1: 2-(Diethylamino)ethanol With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.666667h;
Stage #2: 1-fluoro-2-methoxy-3-nitrobenzene In N,N-dimethyl-formamide at 20℃;
19%
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

1-bromo-2-methoxy-3-fluorobenzene
845829-94-9

1-bromo-2-methoxy-3-fluorobenzene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
View Scheme
Multi-step reaction with 2 steps
1.1: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 20 °C / 2844.39 Torr
2.1: sodium nitrite / water / 1 h / -5 - 0 °C
2.2: 2 h / 0 - 50 °C
View Scheme
Multi-step reaction with 2 steps
1.1: hydrogen; palladium 10% on activated carbon / methanol / 4 h / 20 °C / 2844.39 Torr
2.1: sodium nitrite; hydrogen bromide / water / 1 h / -5 - 0 °C
2.2: 2 h / 0 - 50 °C
View Scheme
Multi-step reaction with 2 steps
1.1: palladium 10% on activated carbon; hydrogen / methanol / 20 °C / 2844.39 Torr
2.1: hydrogen bromide; sodium nitrite / water / 1 h / -5 - 0 °C
2.2: 2 h / 0 - 50 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4-bromo-2-fluoro-3-methoxybenzoic acid
194804-92-7

4-bromo-2-fluoro-3-methoxybenzoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: palladium 10% on activated carbon; hydrogen / methanol / 4 h / 20 °C / 2844.39 Torr
2.1: sodium nitrite / water / 1 h / -5 - 0 °C
2.2: 2 h / 0 - 50 °C
3.1: diisopropylamine; n-butyllithium / tetrahydrofuran / 1 h / -70 °C
View Scheme
Multi-step reaction with 3 steps
1.1: hydrogen; palladium 10% on activated carbon / methanol / 4 h / 20 °C / 2844.39 Torr
2.1: sodium nitrite; hydrogen bromide / water / 1 h / -5 - 0 °C
2.2: 2 h / 0 - 50 °C
3.1: lithium diisopropyl amide / tetrahydrofuran / 1 h / -70 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4-bromo-2-fluoro-3-methoxybenzoic acid chloride

4-bromo-2-fluoro-3-methoxybenzoic acid chloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

ethyl 3-(4-bromo-2-fluoro-3-methoxyphenyl)-3-oxopropionate
194804-99-4

ethyl 3-(4-bromo-2-fluoro-3-methoxyphenyl)-3-oxopropionate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

7-bromo-9-cyclopropyl-8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-dione
846564-00-9

7-bromo-9-cyclopropyl-8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-dione

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
6.1: sodium hydride / dimethylformamide / 0 - 20 °C
6.2: 76 percent / dimethylformamide / 24 h / 20 °C
7.1: sodium hydride / dimethylformamide / 72 h / 75 °C
8.1: 290.9 mg / m-chloroperbenzoic acid / CH2Cl2 / 1 h / 20 °C
9.1: sodium hydrosulfide / dimethylformamide / 1 h / 50 °C
10.1: 121.9 g / aq. NaHCO3; hydroxylamine-O-sulfonic acid / tetrahydrofuran / 2.5 h / 20 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

ethyl 7-bromo-1-cyclopropyl-8-methoxy-2-methylsulfanyl-4-oxo-1,4-dihydroquinoline-3-carboxylate
846563-98-2

ethyl 7-bromo-1-cyclopropyl-8-methoxy-2-methylsulfanyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
6.1: sodium hydride / dimethylformamide / 0 - 20 °C
6.2: 76 percent / dimethylformamide / 24 h / 20 °C
7.1: sodium hydride / dimethylformamide / 72 h / 75 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

ethyl 7-bromo-1-cyclopropyl-2-mercapto-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
846564-01-0

ethyl 7-bromo-1-cyclopropyl-2-mercapto-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
6.1: sodium hydride / dimethylformamide / 0 - 20 °C
6.2: 76 percent / dimethylformamide / 24 h / 20 °C
7.1: sodium hydride / dimethylformamide / 72 h / 75 °C
8.1: 290.9 mg / m-chloroperbenzoic acid / CH2Cl2 / 1 h / 20 °C
9.1: sodium hydrosulfide / dimethylformamide / 1 h / 50 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

ethyl 7-bromo-1-cyclopropyl-2-methanesulfinyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
846563-99-3

ethyl 7-bromo-1-cyclopropyl-2-methanesulfinyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
6.1: sodium hydride / dimethylformamide / 0 - 20 °C
6.2: 76 percent / dimethylformamide / 24 h / 20 °C
7.1: sodium hydride / dimethylformamide / 72 h / 75 °C
8.1: 290.9 mg / m-chloroperbenzoic acid / CH2Cl2 / 1 h / 20 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

ethyl 2-(4-bromo-2-fluoro-3-methoxybenzoyl)-3-cyclopropylamino-3-methylsulfanylacrylate

ethyl 2-(4-bromo-2-fluoro-3-methoxybenzoyl)-3-cyclopropylamino-3-methylsulfanylacrylate

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: H2 / Pd/C / methanol / 27 h / 20 °C
2.1: aq. HBr; NaNO2 / 0 - 5 °C
2.2: CuBr; aq. HBr / 60 °C
3.1: LDA / tetrahydrofuran; hexane / 1.5 h / -78 °C
3.2: tetrahydrofuran; hexane / -78 - 20 °C
4.1: oxalyl chloride; DMF / CH2Cl2 / 20 °C
5.1: n-BuLi / hexane; tetrahydrofuran / -78 °C
5.2: 4.70 g / hexane; tetrahydrofuran; CH2Cl2 / -78 - 10 °C
6.1: sodium hydride / dimethylformamide / 0 - 20 °C
6.2: 76 percent / dimethylformamide / 24 h / 20 °C
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

3-fluorosalicylaldehyde
394-50-3

3-fluorosalicylaldehyde

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 94 percent / hydrogen / 5percent Pd/C / ethyl acetate / 24 h
3: 84 percent / 48percent HBr / 4.5 h / Heating
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

fluoro-3 methoxy-2 benzaldehhyde
74266-68-5

fluoro-3 methoxy-2 benzaldehhyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 94 percent / hydrogen / 5percent Pd/C / ethyl acetate / 24 h
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

1,3-difluoro-2-methoxybenzene
437-82-1

1,3-difluoro-2-methoxybenzene

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

1,3-difluoro-2-methoxy-5-nitrobenzene
392-25-6

1,3-difluoro-2-methoxy-5-nitrobenzene

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

3,5-difluoro-4-methoxyaniline
363-47-3

3,5-difluoro-4-methoxyaniline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

3,5-difluoro-4-methoxyphenol
443-42-5

3,5-difluoro-4-methoxyphenol

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
5: aqueous H2SO4; aqueous CuSO4-solution; xylene / Diazotization
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4-nitro-benzoic acid-(3-fluoro-2-methoxy-anilide)
345-47-1

4-nitro-benzoic acid-(3-fluoro-2-methoxy-anilide)

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: platinum / Hydrogenation
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4-nitro-benzoic acid-(3,5-difluoro-4-methoxy-anilide)
363-48-4

4-nitro-benzoic acid-(3,5-difluoro-4-methoxy-anilide)

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

5-(2,6-diiodo-4-nitro-phenoxy)-1,3-difluoro-2-methoxy-benzene
348-92-5

5-(2,6-diiodo-4-nitro-phenoxy)-1,3-difluoro-2-methoxy-benzene

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
5: aqueous H2SO4; aqueous CuSO4-solution; xylene / Diazotization
6: K2CO3; pentanone-(2)
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4,4'-dimethoxy-3,3',5,5'-tetrafluoroazoxybenzene
499-43-4

4,4'-dimethoxy-3,3',5,5'-tetrafluoroazoxybenzene

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
View Scheme
1-fluoro-2-methoxy-3-nitrobenzene
484-94-6

1-fluoro-2-methoxy-3-nitrobenzene

4-(3,5-difluoro-4-methoxy-phenoxy)-3,5-diiodo-aniline; hydrochloride
400-84-0

4-(3,5-difluoro-4-methoxy-phenoxy)-3,5-diiodo-aniline; hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: platinum / Hydrogenation
2: concentrated aqueous HCl / Diazotization.anschliessende Behandlung mit NaBF4 und Erhitzen des erhaltenen Diazonium-tetrafluoroborats unter vermindertem Druck
3: concentrated H2SO4; HNO3
4: platinum; methanol / Hydrogenation
5: aqueous H2SO4; aqueous CuSO4-solution; xylene / Diazotization
6: K2CO3; pentanone-(2)
7: tin (II)-chloride; acetic acid
View Scheme

484-94-6Relevant academic research and scientific papers

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

-

, (2016/10/06)

The present invention provides compounds of Formula Ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

-

, (2014/09/03)

The present invention provides compounds of Formula(I) or a pharmaceutically acceptable salt thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure, kidney disease, edema, and conditions associated with excessive salt and water retention.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

-

, (2013/03/26)

The present invention provides compounds of Formula Ia and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and conditions associated with excessive salt and water retention.

Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: Effects of structural modifications at the 6-, 7-, and 8-positions

Wang, Qiuping,Lucien, Edlaine,Hashimoto, Akihiro,Pais, Godwin C. G.,Nelson, David M.,Song, Yongsheng,Thanassi, Jane A.,Marlor, Christopher W.,Thoma, Christy L.,Cheng, Jijun,Podos, Steven D.,Ou, Yangsi,Deshpande, Milind,Pucci, Michael J.,Buechter, Douglas D.,Bradbury, Barton J.,Wiles, Jason A.

, p. 199 - 210 (2007/10/03)

We describe the biological evaluation of isothiazoloquinolones (ITQs) having structural modifications at the 6-, 7-, and 8-positions. Addition of a methoxy substituent to C-8 effected an increase in antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and a decrease in cytotoxic activity against Hep2 cells. Removal of fluorine from C-6 or replacement of the C-8 carbon with a nitrogen compromised anti-MRSA activity. When the groups attached at C-7 were compared, the anti-MRSA activity decreased in the order 6-isoquinolinyl > 4-pyridinyl > 5-dihydroisoindolyl > 6-tetrahydroisoquinolinyl. The compound with the most desirable in vitro biological profile was 9-cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpyridin-4-yl) -9H-isothiazolo[5,4-b]quinoline-3,4-dione (7g). This ITQ demonstrated (i) strong in vitro anti-MRSA activity (MIC90 = 0.5 μg/mL), (ii) strong inhibitory activities against S. aureus DNA gyrase and topoisomerase IV, with weak activity against human topoisomerase II, (iii) weak cytotoxic activities against three cell lines, and (iv) efficacy in an in vivo murine thigh model of infection employing MRSA.

NEW ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS

-

Page/Page column 51-53, (2008/06/13)

The invention provides certain compounds and salts of Formula I and Formula II:which possess antimicrobial activity. The invention also provides novel synthetic intermediatesuseful in making compounds of Formula I and Formula II. The variables A1, R2, R3, R5, R6, R7, A8, and Rg are defined herein. Certain compounds of Formula I and Formula II disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.

ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS

-

Page/Page column 54-55, (2010/02/11)

The invention provides compounds and salts of Formula (I) and Formula (II): which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula (I) and Formula (II). The variables A1, R2, R3, R5, R6, R7, A8 and R9 are defined herein. Certain compounds of Formula (I) and Formula (II) disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula (I) or Formula (II) and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula (I) or Formula (II) as the only active agent or may contain a combination of a compound of Formula (I) or Formula (II) and one or more other active agents. The invention also provides methods for treating microbial infections in animals.

A novel method for the nitration of simple aromatic compounds

Smith, Keith,Musson, Adam,DeBoos, Gareth A.

, p. 8448 - 8454 (2007/10/03)

Simple aromatic compounds such as benzene, alkylbenzenes, halogenobenzenes, and some disubstituted benzenes are nitrated in excellent yields with high regioselectivity under mild conditions using zeolite β as a catalyst and a stoichiometric quantity of nitric acid and acetic anhydride. The zeolite can be recycled, and the only byproduct is acetic acid, which can be separated easily from the nitration product by distillation; the process is inexpensive and represents an attractive method for the clean synthesis of a range of nitroaromatic compounds. For example, nitration of toluene gives a quantitative yield of mononitrotoluenes, of which 79% is 4-nitrotoluene; fluorobenzene gives a quantitative yield of mononitro compounds, of which 94% is 4-nitrofluorobenzene; and 2-fluorotoluene gives a 96% yield of mononitro products, of which 90% is the 5-nitro isomer and 10% is the 4-nitro isomer.

A Novel Electrophilic Fluorination of Activated Aromatic Rings Using Acetyl Hypofluorite, Suitable also for Introducing (18)F into Benzene Nuclei

Lerman, Ori,Yitzhak, Tor,Hebel, David,Rozen, Shlomo

, p. 806 - 813 (2007/10/02)

Acetyl hypofluorite (1) is a new compound that serves as a novel electrophilic fluorinating agent.It is special in the sense that, while it is very reactive, it is still a milder reagent than other fluoroxy compounds such as CF3OF or CF3COOF.It is synthesized directly from elemental fluorine and is used without any isolation or purification.The hypofluorite 1 reacts efficiently and selectively with activated aromatic rings,particularly phenol and aniline derivatives after suitable protection of the hydroxyl and the amino groups.The net result of the reaction is partly according to classical aromatic electrophilic substitution.Unlike such a substitution, however, the electrophilic fluorine atom of 1 substitutes mainly an ortho hydrogen and only occasionally small amounts of p-fluoro derivatives are found.Evidence supports the mechanism for this aromatic fluorination as being mainly an addition-elimination one.In many cases the electrophilic aromatic fluorinations can replace the classical 60-year-old Balz-Schiemann method, which until today is probably the most used procedure.Since aromatic fluorination with 1 is a very fast reaction and since 1 is produced directly from elemental fluorine, this is probably one of the best ways for introduction of the short-living radioisotope (18)F into activated aromatic rings.This will greatly encourage the synthesis of compounds suitable for use in the rapidly developing field of positron emitting transaxial tomography, which in itself depends on the efficient and easy supply of compounds possessing positron emitting isotopes.

Etude des complexes du cobalt (II) transporteurs d'oxygene: Nouvelle synthese du fluoro-3 hydroxy-2 benzaldehyde

Aymes, Daniel J.,Paris, Michel R.

, p. 175 - 178 (2007/10/02)

Synthetic chelates of cobalt (II) derived from Schiff bases have remarkable behavior of reversibly absorbing and releasing molecular oxygene.Among these, bis (3-fluorosalicylaldehydeethylenediimide) Co (II) (fluomine: Formula A, X=F) is most interesting in allowing to isolate pure oxygen from air, because it absorbs with extreme rapidity 4.43percent of its weight of oxygen.Fluomine is easily prepared from 3-fluorosalicylaldehyde (3FSA), ethylenediamine and cobalt (II) chloride; but substances such as 3-substituted salicylaldehydes have proven to be extremely difficult to prepare in other than small laboratory quantities from the corresponding ortho-substituted phenol.Many author have prepared 3-fluorosalicylaldehyde, as described in patents, but often these syntheses are very long and the yields are generally less than 20percent.We now describe a new synthesis from o-fluorophenol.Nitration of o-fluorophenol with liquid nitrogen dioxide is convenient: - on the one hand, ortho-substitution to the hydroxyl group, is easy, -on the other hand, the para substituted by-product, is reinserted in the course of the synthesis, so that it is possible to minimize loss of the starting phenol, an expensive product. o-Fluorophenol 1 in solution in pentane, at about 0 deg C, is treated with liquid nitrogen dioxide (slight excess).The reaction is rapid and leads to 2-fluoro 6-nitrophenol 2 which remains in solution, and 2-fluoro 4-nitrophenol 7 which cristallizes rapidly (approximatively 50percent of each one). 2-Fluoro 6-nitrophenol 2 is converted into the anisole 3, the NO2 group of which is catalytically reduced by hydrogen into 3-fluoro 2-methoxy-aminobenzene 4.This amine 4 is diazotized, and treated with formaldoxime to lead to 3-fluoro 2-methoxybenzaldehyde 5 (Eb12 = 82 deg C). 3FSA is finally obtained by heating under reflux anisole 5 and a solution of hydrobromic acid (48percent). 2-Fluoro 4-nitrophenol 7 is converted in five steps into 3-fluoro 2-methoxyaminobenzene 4 by the same reactions as these used for its isomer.Finally the total yield of amine 4 from o-fluorophenol is 73percent, and 3FSA is obtained in 25percent yield.No primary amines are required during the isolation, so that no possible contamination of the final product is possible and therefore the fluomine prepared therefrom is not contaminated and deactivated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 484-94-6